5931 - 5940 of 8620 Results
Title
Year
-
OPENTitle: PARKIN, PINK1, and DJ1 analysis in early-onset Parkinson’s disease in IrelandJournal Name: Irish Journal of Medical Science (1971 -)Publisher: Springer Science and Business Media LLCVol: 191Issue #: 2Start Page: 901End Page: 907Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11845-021-02563-wBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9376961Citation Count: 12
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://escholarship.org/content/qt5c21d8ds/qt5c21d8ds.pdfCitation Count: 108
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202309306Citation Count: 9
- Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity2021OPENTitle: Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicityJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 3Issue #: 1Start Page: 96End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1cb00103eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2022/cb/d1cb00103eCitation Count: 11
- Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration2010OPENTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3019295Citation Count: 41
-
OPENTitle: Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 591End Page: 601Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.03.002Best OA location URL: https://doi.org/10.1016/j.nicl.2017.03.002Citation Count: 100
-
OPENTitle: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 2980End Page: 2995Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22822Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/f5e24699-93e4-49fc-a6e3-c3d92fd2d0b9Citation Count: 108
-
OPENTitle: A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0178982End Page: e0178982Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0178982Best OA location URL: https://escholarship.org/content/qt09j8x8r1/qt09j8x8r1.pdfCitation Count: 15
- Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy2023OPENTitle: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106287End Page: 106287Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106287Citation Count: 9
- Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease2021OPENTitle: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2286End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092286Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823Citation Count: 13